Identification of latexin by a proteomic analysis in rat normal articular cartilage

<p>Abstract</p> <p>Background</p> <p>Osteoarthritis (OA) is characterized by degeneration of articular cartilage. Animal models of OA induced are a widely used tool in the study of the pathogenesis of disease. Several proteomic techniques for selective extraction of proteins have provided protein profiles of chondrocytes and secretory patterns in normal and osteoarthritic cartilage, including the discovery of new and promising biomarkers. In this proteomic analysis to study several proteins from rat normal articular cartilage, two-dimensional electrophoresis and mass spectrometry (MS) were used. Interestingly, latexin (LXN) was found. Using an immunohistochemical technique, it was possible to determine its localization within the chondrocytes from normal and osteoarthritic articular cartilage.</p> <p>Results</p> <p>In this study, 147 proteins were visualized, and 47 proteins were identified by MS. A significant proportion of proteins are involved in metabolic processes and energy (32%), as well as participating in different biological functions including structural organization (19%), signal transduction and molecular signaling (11%), redox homeostasis (9%), transcription and protein synthesis (6%), and transport (6%). The identified proteins were assigned to one or more subcellular compartments.</p> <p>Among the identified proteins, we found some proteins already recognized in other studies such as OA-associated proteins. Interestingly, we identified LXN, an inhibitor of mammalian carboxypeptidases, which had not been described in articular cartilage. Immunolabeling assays for LXN showed a granular distribution pattern in the cytoplasm of most chondrocytes of the middle, deep and calcified zones of normal articular cartilage as well as in subchondral bone. In osteoarthritic cartilage, LXN was observed in superficial and deep zones.</p> <p>Conclusions</p> <p>This study provides the first proteomic analysis of normal articular cartilage of rat. We identified LXN, whose location was demonstrated by immunolabeling in the chondrocytes from the middle, deep and calcified zones of normal articular cartilage, and superficial and deep zones of osteoarthritic cartilage.</p

The orosomucoid 1 protein (α1 acid glycoprotein) is overexpressed in odontogenic myxoma

Odontogenic myxoma (OM) is a benign, but locally invasive, neoplasm occurring in the jaws. However, the molecules implicated in its development are unknown. OM as well as Dental Follicle (DF), an odontogenic tissue surrounding the enamel organ, is derived from ectomesenchymal/mesencyhmal elements. To identify some protein that could participate in the development of this neoplasm, total proteins from OM were separated by two-dimensional electrophoresis and the profiles were compared with those obtained from DF, used as a control

Applied genomic in cerebrovascular disease

Las enfermedades cerebrovasculars implican las alteraciones causadas por el proceso patológico de los vasos sanguíneos, que afectan a una o varias áreas del cerebro. La enfermedad cerebro-vascular también se conoce como ictus o ictus; Es la tercera causa de muerte en todo el mundo y es la patología neurológica con mayor tasa de prevalencia. La enfermedad cerebrovascular induce varios cambios en la expresión genética dentro de la unidad neurovascular (células gliales, neuronas y células ependimales); Principalmente, los cambios en el estrés oxidativo y la entrada de calcio en las células, podrían iniciar la muerte celular y la destrucción del tejido, causando una lesión irreversible en el cerebro, perdiendo varias funciones. La lesión hace que la activación de las vías de señalización responda al estrés, donde muchas moléculas, como las proteínas y el ARNm, actúan como intermediarios para activar o desactivar los mecanismos de estrés; estas moléculas son capaces de transmitir señales extracelulares en el núcleo activando la expresión génica temprana como protooncogenes y varios factores de transcripción para reparar la lesión cerebral. Es importante conocer la relación de los cambios en la expresión genética y las proteínas para evitar el desarrollo de lesiones y activar la recuperación del cerebro. Este conocimiento nos permite diagnosticar la tasa de lesiones y proponer mecanismos terapéuticos para reducir o evitar los efectos adversos a tiempo, antes de que comience la muerte celular

The orosomucoid 1 protein (α1 acid glycoprotein) is overexpressed in odontogenic myxoma

Abstract Background Odontogenic myxoma (OM) is a benign, but locally invasive, neoplasm occurring in the jaws. However, the molecules implicated in its development are unknown. OM as well as Dental Follicle (DF), an odontogenic tissue surrounding the enamel organ, is derived from ectomesenchymal/mesencyhmal elements. To identify some protein that could participate in the development of this neoplasm, total proteins from OM were separated by two-dimensional electrophoresis and the profiles were compared with those obtained from DF, used as a control. Results We identified eight proteins with differential expression; two of them were downregulated and six upregulated in OM. A spot consistently overexpressed in odontogenic myxoma, with a molecular weight of 44-kDa and a pI of 3.5 was identified as the orosomucoid 1 protein. Western blot experiments confirmed the overexpression of this protein in odontogenic myxoma and immunohistochemical assays showed that this protein was mainly located in the cytoplasm of stellate and spindle-shaped cells of this neoplasm. Conclusion Orosomucoid 1, which belongs to a group of acute-phase proteins, may play a role in the modulation of the immune system and possibly it influences the development of OM.</p

Reporte PAP Servicios de Atención Clínica Interdisciplinaria primavera 2022

El Proyecto de Aplicación Profesional Atención Clínica Interdisciplinaria tiene sus orígenes en el PAP que desde hace más de 10 años está vinculado con el DIF Zapopan y que en un principio estaba más fundamentado en una base psicoanalítica. Actualmente, el proyecto se ofrece desde el Departamento de Psicología, Educación y Salud del ITESO con el objetivo de ofrecer servicios de atención y orientación profesional a los usuarios que la solicitan para encontrar respuesta a los diferentes motivos de consulta psicológica y nutricional que sean referidos. Como parte del contexto actual del COVID-19 y del retorno a la presencialidad que se ha suscitado desde agosto del 2021, el proyecto ha contribuido a ofrecer un espacio de atención en modalidad híbrida (presencial y en línea) a la salud integral de los usuarios de los diferentes escenarios. La concepción de interdisciplina atañe principalmente a las licenciaturas de Psicología, Nutrición y Derecho para que de manera coordinada se ofrezcan servicios que logren hacer un buen diagnóstico, planeación e intervención en problemáticas tales como la violencia de género, el maltrato infantil, la depresión, la ansiedad y el desarrollo de una vida saludable en los aspectos nutricionales, emocionales y de acceso a la justicia. En el presente documento se presentan los avances más significativos de los servicios de atención clínica que se ofrecen, así como de los productos que para cada escenario el proyecto desarrolló durante el periodo de primavera de 2022.ITESO, A.C